Ā | SLE (nā=ā63) | Controls (nā=ā18) | p value |
---|---|---|---|
Age, years | 39 (29ā63) | 41 (30ā61) | 0.357 |
Female gender, n (%) | 52 (82.5) | 14 (77.8) | 0.646 |
Smoker current, n (%) | 24 (38.1) | 8 (44.4) | 0.627 |
LDL cholesterol, g/L | 0.90 (0.36ā1.53) | 1.22 (0.74ā1.72) | 0.001 |
Hypertension, n (%) | 16 (25.4) | 4 (22.2) | 0.783 |
SBP, mm Hg | 125 (100ā166) | 125 (108ā184) | 0.498 |
10-Year cardiovascular riska, % | 1 (1ā18) | 1 (1ā13) | 0.416 |
Overweightb, n (%) | 24 (38.1) | 8 (44.4) | 0.627 |
Waist circumference, cm | 90 (74ā150) | 91 (74ā117) | 0.852 |
eGFRc, mL/min/1.73Ā m2 | 92 (54ā127) | 76 (60ā99) | 0.221 |
HbA1c, % | 5.5 (4.4ā6.7) | 5.5 (4.6ā6.5) | 0.988 |
Antiplatelet treatment, n (%) | 7 (11.1) | 1 (5.6) | 0.486 |
Statin, n (%) | 15 (23.8) | 2 (11.1) | 0.139 |
ACE inhibitors, n (%) | 16 (25.4) | 3 (16.7) | 0.440 |
ARBs, n (%) | 5 (7.9) | 0 | 0.217 |
Carotid plaqued, n (%) | 23 (36.5) | 2 (11.1) | 0.039 |